Intrinsiqq
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc.

ABOS

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$13M
EPS-$1.53
P/E-0.12
P/FCF-0.15
EV/EBITDA0.37
FCF Yield–
Div. Yield–
Net Debt/FCF0.6x
Acumen Pharmaceuticals, Inc. intrinsic value
52-Week Range
$0.19$0.24

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$104M

▼ -18.6% YoY

Op. Margin

–

ROIC

-89.38%

▼ -27.1pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$88M

▼ -34.1% YoY

Op. Cash Flow (TTM)

-$88M

▼ -34.0% YoY

Net Debt

-$52M

Net Cash Position

Cash & Equiv.

$79M

Continue Research

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ABOS

CompareIntrinsic value
PALIPalisade Bio Inc.
$0.84-9.69%20
VYGRVoyager Therapeutics Inc.
$1.53-4.97%10
FENCFennec Pharmaceuticals Inc.
$13.10-2.60%50
RGNXRegenxbio Inc.
$7.16-0.28%36
NVAXNovavax Inc.
$7.47-3.24%25
TECHBio-Techne Corporation
$72.67-0.04%41
CHRSCoherus Biosciences Inc.
$0.37-4.44%10
LCTXLineage Cell Therapeutics Inc.
$0.77-5.87%10

Held by ETFs

ABOS is in 2 US ETFs. The largest of them, with ABOS's weight in each:

Acumen Pharmaceuticals (ABOS) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.12
Negative: a loss over the last twelve months. Price to free cash flow -0.15.
Financials

Questions about Acumen Pharmaceuticals

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

No. Acumen Pharmaceuticals (ABOS) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 21 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in ABOS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ABOS

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.